WEISMAN HOWARD J. (Chief Executive Officer) sold 6.2% of their position (35.89K shares) of KUVATRIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $52.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/9/2023ACC: 0001104659-23-030761
DirectorOfficer· Chief Executive Officer
Since Aug 2022
-35.89K
Net shares
Net seller
$52.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
35.89K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−32.40K
Price / share
$1.46
Trade value
$47.30K
% of position
5.6%
3/8/2023
577.52K→545.13K
Common Stock
Direct
Shares
−3.50K
Price / share
$1.44
Trade value
$5.03K
% of position
0.6%
3/9/2023
545.13K→541.63K
Total
Net shares
−35.89K
Net value
-$52.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/8/2023 | S · Sale | −32.40K | $1.46 | $47.30K | 5.6% | 577.52K | 545.13K |
| Common Stock Direct | 3/9/2023 | S · Sale | −3.50K | $1.44 | $5.03K | 0.6% | 545.13K | 541.63K |
| Total | −35.89K | -$52.33K | ||||||
Derivative Transactions0
No derivative transactions reported